Celularity (CELU) Short term Debt (2018 - 2025)
Celularity (CELU) posted quarterly Short term Debt of $9.6 million for Q4 2025, up 284.83% year-over-year from $2.5 million in Q4 2024, and up 123.23% quarter-over-quarter from $4.3 million in Q3 2025.
Celularity (CELU) Short term Debt (2018 - 2025) Analysis & Trends
Celularity (CELU) has reported Short term Debt for 5 consecutive years, with $9.6 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Short term Debt rose 284.83% year-over-year to $9.6 million; the TTM figure through Dec 2025 stood at $9.6 million (up 284.83% YoY), while the FY2025 annual figure was $9.6 million, up 284.83% from the prior year.
- Short term Debt advanced to $9.6 million in Q4 2025 per CELU's latest filing, from $4.3 million in the prior quarter.
- Across five years, Short term Debt topped out at $39.3 million in Q3 2022 and bottomed at $2.5 million in Q4 2024.
- Historically, Short term Debt has averaged $16.1 million across 4 years, with a median of $14.0 million in 2023.
- Annual changes were most pronounced in 2024 — Short term Debt sank 85.57% — and 2025, when it soared 284.83%.
- Celularity's Short term Debt stood at $37.6 million in 2022, then plunged by 54.2% to $17.2 million in 2023, then tumbled by 85.57% to $2.5 million in 2024, then jumped by 284.83% to $9.6 million in 2025.
- Business Quant data shows CELU's Short term Debt at $9.6 million in Q4 2025, $4.3 million in Q3 2025, and $2.6 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Celularity | 20.99 Mn | 14.82 Mn | -3.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9.56 Mn |
| Sep 30, 2025 | 4.28 Mn |
| Jun 30, 2025 | 2.65 Mn |
| Mar 31, 2025 | 2.49 Mn |
| Dec 31, 2024 | 2.49 Mn |
| Dec 31, 2023 | 17.22 Mn |
| Sep 30, 2023 | 14.01 Mn |
| Jun 30, 2023 | 16.82 Mn |
| Mar 31, 2023 | 30.95 Mn |
| Dec 31, 2022 | 37.60 Mn |
| Sep 30, 2022 | 39.26 Mn |
| Dec 31, 2018 | 150,000.00 |